BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8342961)

  • 1. Mast cell tryptase and chymase in developing and mature psoriatic lesions.
    Harvima IT; Naukkarinen A; Paukkonen K; Harvima RJ; Aalto ML; Schwartz LB; Horsmanheimo M
    Arch Dermatol Res; 1993; 285(4):184-92. PubMed ID: 8342961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin.
    Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
    Arch Dermatol Res; 1990; 282(7):428-33. PubMed ID: 1706585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
    Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M
    Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin.
    Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
    Int J Dermatol; 1994 May; 33(5):361-6. PubMed ID: 8039976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema.
    Järvikallio A; Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
    Br J Dermatol; 1997 Jun; 136(6):871-7. PubMed ID: 9217819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus.
    Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
    Acta Derm Venereol; 1991; 71(5):394-8. PubMed ID: 1721758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
    Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
    Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
    J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors.
    Kaminska R; Naukkarinen A; Glinski W; Horsmanheimo M; Harvima IT
    Acta Derm Venereol; 1999 Sep; 79(5):351-5. PubMed ID: 10494709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme histochemical discrimination between tryptase and chymase in mast cells of human gut.
    Osman IA; Garrett JR; Smith RE
    J Histochem Cytochem; 1989 Apr; 37(4):415-21. PubMed ID: 2647838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis.
    Badertscher K; Brönnimann M; Karlen S; Braathen LR; Yawalkar N
    Arch Dermatol Res; 2005 Apr; 296(10):503-6. PubMed ID: 15703960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
    Kivinen PK; Kaminska R; Naukkarinen A; Harvima RJ; Horsmanheimo M; Harvima IT
    Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
    Lipitsä T; Naukkarinen A; Harvima IT
    Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin.
    Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
    Allergy; 2001 Jan; 56(1):58-64. PubMed ID: 11167353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of tryptase in bovine cutaneous and tumor mast cells.
    Welle MM; Proske SM; Harvima IT; Schechter NM
    J Histochem Cytochem; 1995 Nov; 43(11):1139-44. PubMed ID: 7560896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M; Harvima IT
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy.
    Riekki R; Harvima IT; Jukkola A; Risteli J; Oikarinen A
    Exp Dermatol; 2004 Jun; 13(6):364-71. PubMed ID: 15186323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin.
    Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
    Clin Exp Allergy; 2001 Apr; 31(4):593-601. PubMed ID: 11359428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions.
    Kankkunen JP; Harvima IT; Naukkarinen A
    Int J Cancer; 1997 Jul; 72(3):385-8. PubMed ID: 9247277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds.
    Huttunen M; Aalto ML; Harvima RJ; Horsmanheimo M; Harvima IT
    Exp Dermatol; 2000 Aug; 9(4):258-65. PubMed ID: 10949547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.